JUPITER NEUROSCIENCES, INC. — Form 8-K
Filed August 24, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Jupiter Neurosciences sold 307,692 shares of common stock at $6.50 per share (gross proceeds $2.0M) in a registered direct offering using an effective Form S-3 (File No. 333-295085, effective April 24, 2026). D. Boral Capital LLC is the exclusive placement agent (7% cash fee plus up to $75K expenses). Closing expected August 24, 2026. Pre-funded warrants (exercise price $0.0001) also offered; shares issued free of legends. Lock-up agreements for insiders/5%+ holders for 30 days post-closing.
Why this rating
At $20.2M market cap, a $2M raise is ~10% of company size—material for liquidity but routine for clinical-stage biotech. Executed via shelf registration (standard). No new business model changes disclosed.
See more from August 24, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.